Search Results 131-140 of 16031 for melatonin receptor agonists
A Phase II study to investigate the potential utility of PD 0332991 in the treatment of early stage ER+ Human epidermal growth factor receptor 2 (HER2)- breast ...
"The light that is emitted by the electronic device may also suppress melatonin secretion. Melatonin is the sleep-inducing hormone that is secreted by the ...
2010 May;13:(5):10-11. Kolla BP, Mansukhani MP, Barraza R, Bostwick JM. Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole- ...
It is not yet known whether letrozole is more effective than a placebo in treating patients with hormone receptor-positive breast cancer. PURPOSE: This ...
Mayo Clinic experts in sleep medicine diagnose and treat people who have sleep problems and disorders. This includes doctors called pulmonologists, trained in ...
... receptor (MC4R) pathway who achieve a clinically meaningful reduction in ... Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to ...
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer. Print ...
REM sleep behavior disorder is a sleep disorder in which you physically and vocally act out vivid, often unpleasant dreams during REM sleep.
No uniformly effective therapy exists for Graves' ophthalmology. Insights into the important role of TSH receptor and TRAb in the development of the tissue ...
Use of medications that could cross react with or augment alcohol (benzodiazepines, benzodiazepine receptor agonists, opioids) and any sleeping medication.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.